L-arginin in prevention and treatment of pre-eclampsia


Authors: L. Vacula
Authors‘ workplace: Gynekologicko-porodnické oddělení, Kroměřížská nemocnice, a. s., Kroměříž, primář MUDr. J. Přibík
Published in: Čes. Gynek.2013, 78, č. 2 s. 181-186

Overview

Objective:
It is to show the possible relationship between the patofysiology of pre-eclampsia in the body of a human with a relative lack of L-arginine and its potential connection with a nitrogen metabolism. This study also suggests the further utilization of above mentioned knowledges in a prevention and a treatment of pre-eclampsia.

Design:
Literary overview.

Setting:
Gynaecology and Obstetric Department of the Hospital Kromeriz, Inc., Kromeriz.

Methods:
The background research of studies and issues published already in medical professional journals, bulletins and medical web databases.

Conclusion:
To provide L-arginine to pregnant women as a dietary supplement concerns no risk and is an easy precaution. L-arginine can reduce the occurrance of pre-eclampsia in women with a potential high risk of its developement. The most important transmitter substance that makes L-arginine work is the dioxide nitrogen. So far, it has been the outmost possibility how to influence the patofysiology of Pre-eclampsia The lack of L-arginine and its influence on the nitrogen metabolism is likely, but there is also a great need for further research.

Keywords:
pre-eclampsia – L-arginine – dioxide nitrogen – NO synthase – dysfunction of endothelium – urea cycle


Sources

1. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet, 2002, 77, 33, p. 67–75.

2. Argininemia, hyperargininemia, arginase deficiency, Metabolic Information Center [on line]. Dostupný na www: <http://www.metagene.de/program/d.prg?mp=ARGININEMIA.%20HYPERARGININEMIA,%20ARGINASE%20DEFICIENCY>

3. Arginin – Wikipedia [on line], dostupný na www: <http://en.wikipedia.org/wiki/Arginine>

4. Bultas, J., Cífková, R., Češka, R., et al. Od endoteliální dysfunkce k ischemické chorobě srdeční. Praha: Galén 1999. 127 s.

5. Burger, O., Pick, E., Zwickel, J. Placental protein 13 (PP-13): Effect on cultured trophoblasts and its detection in human body fluids in normal and pathological pregnancies. Placenta, 2004, 25, p. 608–622.

6. Chaiworapongsa, T., Romero, R., Espinosa, J., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol, 2004, 190, p. 1541–1550.

7. D´Anna, R., Baviera, G., Corrado, F., et al. Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. BJOG, 2004, 111, p. 1046–1050.

8. De Vivo, A., Baviera, G., Giordano, D., et al. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand, 2008, 87, 8, p. 837–842.

9. Glutamat – Human pathology [on line] 2004-5-3, dostupný na www: <http://www.humpath.com/spip.php?article3229>

10. Griffith, OW., Stuehr, DJ. Ann Rev Physiol, 1995, 57, p. 707–736.

11. Grill, S., Rusterholz, C., Zanetti-Dällenbach, R. Potential markers of preeclampsia – a review. Reprod Biol Endocrinol, 2009, 14, 7, p. 70.

12. Habilitační práce Václava Hampla Úloha oxidu dusnatého v normálním plicním oběhu a při plicní hypertenzi, Praha 1997, [on line]. Dostupný na www: <http://fyziologie.lf2.cuni.cz/hampl/habilit/index.htm>

13. Holthe, MR., Staff, AC., Berge, LN., Lyberg, T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol, 2004, 190, p. 1128–1134.

14. Isabella Neri, Jasonni, VM., Gori, GF., et al. Effect of l-arginine on blood pressure in pregnancy-induced hypertension: A randomized placebo-controlled trial. J Mater Fetal Neonatal Med, 2006, 19, 5, p. 277–281.

15. Měchurová, A. Preeklampsie. In Hájek, Z., a kol. Rizikové a patologické těhotenství. Praha: Grada Publishing, 2004, s. 95–107.

16. Moretii, M., Phillips, M., Abdouzeid, A., et al. Increasedbreath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol, 2004, 190, p. 1184–1190.

17. Murray, RK., et al. Harperova biochemie. Z angl. 23. vyd. přel. Lenka Fialová et. al. 4. vyd. v ČR. Praha: H & H, 2002. 872 s.

18. Parsons, CG., Danysz, W., Quack, G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data. Neuropsychopharmacology, 1999, 38, p. 735–767.

19. Piťha, J., Roztočil, K., Cífková, R., et al. Endoteliální dysfunkce a její hodnocení. Cor Vasa, 2001, 43, s. 452–456.

20. Poznámky k přednášce Václava Hampla – Oxid dusnatý [on line]. 2000-03-23, dostupný na www: <http://fyziologie.lf2.cuni.cz/hampl/teach_mat/nitricox/index.htm>

21. Rogawski, MA., Wenk, GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer ´s disease. CNS Drugs Reviews, 2003, 9, p. 275–308.

22. Romero, R., Kusanovic, JP., Than, NG., et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia.Am J Obstet Gynecol, 2007, 14, 2, p. 46–54.

23. Savvidou, MD., Hingorani, AD., Tsikas, D., et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimetylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet, 2003, 361, p. 1511–1517.

24. Stepan, H., Unversucht, A., Wessel, N., et al. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension, 2007, 49, 4, p. 818–824.

25. St-Jacques, S., Forte, M., Lye, SJ., et al.: Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod, 1994, 51, p. 195, p. 255–259.

26. Suzuki, Y., Yamamoto, T., Matsuura, A.: PP049. Could the supplementation of L-arginine plus folic acid T improve reduced endothelial function seen in preeclampsia? Pregnancy Hypertension, 2012; 2, 3, p. 268.

27. Vadillo-Ortega, F., et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on preeclampsia in high risk population: randomized controlled trial, 2011-19-05, [on line], dostupný na www: <http://www.bmj.com/content/342/bmj.d2901>

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account